The β3 Nicotinic Receptor Subunit: A Component of α-Conotoxin MII-Binding Nicotinic Acetylcholine Receptors that Modulate Dopamine Release and Related Behaviors
Open accessAbstract
Nigrostriatal dopaminergic neurons express many nicotinic acetylcholine receptor (nAChR) subunits capable of forming multiple nAChR subtypes. These subtypes are expressed differentially along the neuron and presumably mediate diverse responses. β3 subunit mRNA has restricted expression but is abundant in the substantia nigra and ventral tegmental areas. To investigate the potential role(s) of nicotinic receptors containing the β3 subunit in dopaminergic tracts, we generated mice with a null mutation in the β3 gene. We were thereby able to identify a population of β3-dependent α-conotoxin MII-binding nAChRs that modulate striatal dopamine release. Changes were also observed in locomotor activity and prepulse inhibition of acoustic startle, behaviors that are controlled, in part, by nigrostriatal and mesolimbic dopaminergic activity, respectively, suggesting that β3-containing nAChRs modulate these behaviors.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
β3 mRNA is detected in the substantia nigra, VTA, and medial habenula.
“As β3 mRNA is detected in the substantia nigra, VTA, and medial habenula (Cui et al. 2003)”
From Nicotine Withdrawal (2015) · cites this paper as Cui et al. 2003
Locomotor activity and prepulse inhibition of acoustic startle are controlled at least partly by nigrostriatal and mesolimbic dopaminergic activity.
“behaviors that are controlled, at least in part, by nigrostriatal and mesolimbic dopaminergic activity (Cui et al. 2003)”
From Nicotine Withdrawal (2015) · cites this paper as Cui et al. 2003
β3 knockout mice show changes in locomotor activity and prepulse inhibition of acoustic startle.
“Changes were also reported for locomotor activity and prepulse inhibition of acoustic startle”
From Nicotine Withdrawal (2015) · cites this paper as Cui et al. 2003
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter
Giros, B., Jaber, M., Jones, S. R., Wightman, R. M., & Caron, M. G. (1996) · Nature · doi:10.1038/379606a0 · Cited by 2,476 · see citing works
Visualizing an Olfactory Sensory Map
Mombaerts, P., Wang, F., Dulac, C. G., Chao, S. K., Nemes, A., Mendelsohn, M. M., Edmondson, J., & Axel, R. (1996) · Cell · doi:10.1016/s0092-8674(00)81387-2 · Cited by 1,992 · see citing works
Geyer, M. A., Krebs-Thomson, K., Braff, D. L., & Swerdlow, N. R. (2001) · Psychopharmacology · doi:10.1007/s002130100811 · Cited by 1,484 · see citing works
Séguéla, P., Wadiche, J. I., Dineley‐Miller, K., Dani, J., & Jw, P. (1993) · Journal of Neuroscience · doi:10.1523/jneurosci.13-02-00596.1993 · Cited by 1,471 · see citing works
Presynaptic nicotinic ACh receptors
Wonnacott, S. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)10073-4 · Cited by 1,308 · see citing works
Flores, C. M., Rogers, S. W., Pabreza, L. A., Wolfe, B. B., & Kellar, K. J. (1992) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)08832-7 · Cited by 880 · see citing works
Klink, R., d'Exaerde, A. D. K., Zoli, M., & Changeux, J.-P. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-05-01452.2001 · Cited by 674 · see citing works
Elgoyhen, A. B., Vetter, D. E., Katz, E., Rothlin, C. V., Heinemann, S. F., & Boulter, J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051622798 · Cited by 673 · see citing works
Self-citationAbnormal avoidance learning in mice lacking functional high-affinity nicotine receptor in the brain
Picciotto, M. R., Zoli, M., Léna, C., Bessis, A., Lallemand, Y., LeNovère, N., Vincent, P., Pich, E. M., Brûlet, P., & Changeux, J.-P. (1995) · Nature · doi:10.1038/374065a0 · Cited by 668 · see citing works
The new mouse genetics: Altering the genome by gene targeting
Capecchi, M. R. (1989) · Trends in Genetics · doi:10.1016/0168-9525(89)90029-2 · Cited by 611 · see citing works
Dopamine receptors and brain function
Jaber, M., Robinson, S. W., Missale, C., & Caron, M. G. (1996) · Neuropharmacology · doi:10.1016/s0028-3908(96)00100-1 · Cited by 572 · see citing works
Nicotine binding and nicotinic receptor subunit RNA after chronic nicotine treatment
Marks, M., Pauly, Jr., Gross, S., Deneris, E., Hermans-Borgmeyer, I., Heinemann, S., & Collins, A. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-07-02765.1992 · Cited by 551 · see citing works
Self-citationReduced antinociception in mice lacking neuronal nicotinic receptor subunits
Marubio, L. M., Jiménez, M. D. M. A., Cordero‐Erausquin, M., Léna, C., Novère, N. G. L., d’Exaerde, A. D. K., Huchet, M., Damaj, M. I., & Changeux, J. (1999) · Nature · doi:10.1038/19756 · Cited by 533 · see citing works
Orr‐Urtreger, A., Göldner, F. M., Saeki, M., Lorenzo, I., Goldberg, L. B., Biasi, M. D., Dani, J. A., Patrick, J. W., & Beaudet, A. L. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-23-09165.1997 · Cited by 494 · see citing works
Schoepfer, R., Conroy, W. G., Whiting, P. J., Gore, M., & Lindstrom, J. M. (1990) · Neuron · doi:10.1016/0896-6273(90)90031-a · Cited by 473 · see citing works
A Simple Genetic Basis for a Complex Psychological Trait in Laboratory Mice
Jonathan Flint, C., Corley, R. P., DeFries, J. C., Fulker, D. W., Gray, J. A., Miller, S., & Collins, A. C. (1995) · Science · doi:10.1126/science.7660127 · Cited by 438 · see citing works
Self-citationZoli, M., Moretti, M., Zanardi, A., McIntosh, J. M., Clementi, F., & Gotti, C. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-20-08785.2002 · Cited by 407 · see citing works
Self-citationChamptiaux, N., Han, Z., Bessis, A., Rossi, F., Zoli, M., Marubio, L. M., McIntosh, J. M., & Changeux, J. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-04-01208.2002 · Cited by 345 · see citing works
Self-citationWhiting, P. J., & Lindström, J. (1988) · Journal of Neuroscience · doi:10.1523/jneurosci.08-09-03395.1988 · Cited by 262 · see citing works
Azam, L., Winzer‐Serhan, U. H., Chen, Y.-L., & Leslie, F. M. (2002) · The Journal of Comparative Neurology · doi:10.1002/cne.10138 · Cited by 258 · see citing works
A Novel Negative Selection for Homologous Recombinants Using Diphtheria Toxin A Fragment Gene
Yagi, T., Nada, S., Watanabe, N., Tamemoto, H., Kohmura, N., Ikawa, Y., & Aizawa, S. (1993) · Analytical Biochemistry · doi:10.1006/abio.1993.1459 · Cited by 227 · see citing works
β3: A New Member of Nicotinic Acetylcholine Receptor Gene Family Is Expressed in Brain
Deneris, E. S., Boulter, J., Swanson, L. W., Patrick, J., & Heinemann, S. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)83343-9 · Cited by 225 · see citing works
Self-citationHuman α6 AChR subtypes: subunit composition, assembly, and pharmacological responses
Kuryatov, A., Olale, F., Cooper, J., Choi, C. H., & Lindstrom, J. M. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(00)00144-1 · Cited by 223 · see citing works
α-Conotoxin MII Blocks Nicotine-Stimulated Dopamine Release in Rat Striatal Synaptosomes
Kulak, J. M., Nguyen, T. A., Olivera, B. M., & McIntosh, J. M. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-14-05263.1997 · Cited by 198 · see citing works
Self-citationChapter 10 Structure and function of neuronal nicotinic acetylcholine receptors
Lindstrom, J. M., Anand, R., Gerzanich, V., Peng, X.-D., Wang, F., & Wells, G. B. (1996) · Progress in brain research · doi:10.1016/s0079-6123(08)62094-4 · Cited by 179 · see citing works
Jones, I. W., Bolam, J. P., & Wonnacott, S. (2001) · The Journal of Comparative Neurology · doi:10.1002/cne.1345 · Cited by 167 · see citing works
Charpantier, E., Barnéoud, P., Moser, P. C., Besnard, F., & Sgard, F. (1998) · Neuroreport · doi:10.1097/00001756-199809140-00033 · Cited by 166 · see citing works
Kaiser, S., Soliakov, L. S., Harvey, S. C., Luetje, C. W., & Wonnacott, S. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70031069.x · Cited by 160 · see citing works
125I-α-Conotoxin MII Identifies a Novel Nicotinic Acetylcholine Receptor Population in Mouse Brain
Whiteaker, P., McIntosh, J. M., Luo, S., Collins, A. C., & Marks, M. J. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)26500-7 · Cited by 160 · see citing works
Self-citationWhiteaker, P., McIntosh, J. M., Luo, S., Collins, A. C., & Marks, M. J. (2000) · PubMed · Cited by 158 · see citing works
Self-citationDifferential Agonist Inhibition Identifies Multiple Epibatidine Binding Sites in Mouse Brain
Marks, M. J., Smith, K. W., & Collins, A. C. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37384-7 · Cited by 140 · see citing works
Self-citationBullock, A. E., Slobe, B. S., Vázquez, V., & Collins, A. C. (1997) · Behavioral Neuroscience · doi:10.1037//0735-7044.111.6.1353 · Cited by 119 · see citing works
Self-citationGrady, S. R., Murphy, K. L., Cao, J., Marks, M. J., McIntosh, J. M., & Collins, A. C. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.301.2.651 · Cited by 110 · see citing works
Self-citationVulnerability of125I-α-Conotoxin MII Binding Sites to Nigrostriatal Damage in Monkey
Quik, M., Polonskaya, Y., Kulak, J. M., & McIntosh, J. M. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-15-05494.2001 · Cited by 109 · see citing works
Self-citationRalph, R. J., Paulus, M. P., & Geyer, M. A. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29362-9 · Cited by 109 · see citing works
Identification of a novel nicotinic binding site in mouse brain using [125I]‐epibatidine
Whiteaker, P., Jimenez, M., McIntosh, J. M., Collins, A. C., & Marks, M. J. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703616 · Cited by 105 · see citing works
Self-citationBullock, A. E., Slobe, B. S., Vázquez, V., et al. (1997) · Behavioral Neuroscience · doi:10.1037/0735-7044.111.6.1353 · Cited by 103 · see citing works
Tsuneki, H., Klink, R., Léna, C., Korn, H., & Changeux, J. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00138.x · Cited by 98 · see citing works
Formation of Oligomers Containing the β3 and β4 Subunits of the Rat Nicotinic Receptor
Forsayeth, J., & Kobrin, E. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-05-01531.1997 · Cited by 85 · see citing works
Quik, M., Sum, J., Whiteaker, P., McCallum, S. E., Marks, M. J., Musachio, J. L., McIntosh, J. M., Collins, A. C., & Grady, S. R. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.5.1169 · Cited by 83 · see citing works
Self-citationClarke, P. B. S. (1993) · Progress in brain research · doi:10.1016/s0079-6123(08)62383-3 · Cited by 80 · see citing works
Nigral degeneration in parkinson's disease
Rinne, J. O. (1993) · Movement Disorders · doi:10.1002/mds.870080507 · Cited by 62 · see citing works
Exploration and Its Measurement: A Psychopharmacological Perspective
Kelley, A. E., Cador, M., & Stinus, L. (2003) · Humana Press eBooks · doi:10.1385/0-89603-129-2:95 · Cited by 52 · see citing works
Pharmacological and null mutation approaches reveal nicotinic receptor diversity
Whiteaker, P., Marks, M. J., Grady, S. R., Lü, Y., Picciotto, M. R., Changeux, J., & Collins, A. C. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00052-2 · Cited by 51 · see citing works
Self-citationConus peptides: novel probes for nicotinic acetylcholine receptor structure and function
McIntosh, J. M., Gardner, S., Luo, S., Garrett, J. E., & Yoshikami, D. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00887-0 · Cited by 43 · see citing works
Self-citationQuik, M., Polonskaya, Y., Gillespie, A. J., Lloyd, G. K., & Langston, J. W. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00244-x · Cited by 40 · see citing works
β3 subunit is present in different nicotinic receptor subtypes in chick retina
Vailati, S., Moretti, M., Balestra, B., McIntosh, M., Clementi, F., & Gotti, C. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00067-4 · Cited by 39 · see citing works
Stitzel, J. A., Farnham, D. A., & Collins, A. C. (1996) · Molecular Brain Research · doi:10.1016/s0169-328x(96)00149-0 · Cited by 36 · see citing works
Self-citationReuben, M., Boye, S., & Clarke, P. B. S. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00004-2 · Cited by 33 · see citing works
A genetic analysis of nicotine effects on open field activity
Marks, M. J., Miner, L. L., Cole-Harding, S., Burch, J. B., & Collins, A. C. (1986) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(86)90584-8 · Cited by 31 · see citing works
Self-citationNayak, S. V., Dougherty, J. J., McIntosh, J. M., & Nichols, R. A. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00197.x · Cited by 25 · see citing works
Self-citation
Flagged first, then by citations
2 of the 53 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Brain nicotinic acetylcholine receptors: native subtypes and their relevance
Gotti, C., Zoli, M., & Clementi, F. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.07.004 · Cited by 882 · see citing works
Neuronal nicotinic receptors: from structure to pathology
Gotti, C., & Clementi, F. (2004) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2004.09.006 · Cited by 970 · see citing works
Pierce, R. C., & Kumaresan, V. (2006) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.04.016 · Cited by 913 · see citing works
Realistic expectations of prepulse inhibition in translational models for schizophrenia research
Swerdlow, N. R., Weber, M., Qu, Y., Light, G. A., & Braff, D. L. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1072-4 · Cited by 529 · see citing works
Structural and functional diversity of native brain neuronal nicotinic receptors
Gotti, C., Clementi, F., Fornari, A., Gaimarri, A., Guiducci, S., Manfredi, I., Moretti, M., Pedrazzi, P., Pucci, L., & Zoli, M. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.05.024 · Cited by 469 · see citing works
Nicotine addiction and nicotinic receptors: lessons from genetically modified mice
Changeux, J.-P. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2849 · Cited by 453 · see citing works
Salminen, O., Murphy, K. L., McIntosh, J. M., Drago, J., Marks, M. J., Collins, A. C., & Grady, S. R. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.6.1526 · Cited by 401 · see citing works
Self-citationDiversity of vertebrate nicotinic acetylcholine receptors
Millar, N. S., & Gotti, C. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.07.041 · Cited by 441 · see citing works
Govind, A. P., Vezina, P., & Green, W. N. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.06.011 · Cited by 338 · see citing works
Smoking, nicotine and Parkinson's disease
Quik, M. (2004) · Trends in Neurosciences · doi:10.1016/j.tins.2004.06.008 · Cited by 323 · see citing works
Heterogeneity and complexity of native brain nicotinic receptors
Gotti, C., Moretti, M., Gaimarri, A., Zanardi, A., Clementi, F., & Zoli, M. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.05.023 · Cited by 282 · see citing works
Nicotine: from molecular mechanisms to behaviour
Wonnacott, S., Sidhpura, N., & Balfour, D. J. (2005) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2004.12.002 · Cited by 263 · see citing works
The subtypes of nicotinic acetylcholine receptors on dopaminergic terminals of mouse striatum
Grady, S. R., Salminen, O., Laverty, D. C., Whiteaker, P., McIntosh, J. M., Collins, A. C., & Marks, M. J. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.07.032 · Cited by 252 · see citing works
Self-citationExley, R. A., & Cragg, S. J. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707510 · Cited by 249 · see citing works
Exley, R., Clements, M. A., Hartung, H., McIntosh, J. M., & Cragg, S. J. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301617 · Cited by 242 · see citing works
Self-citationGrady, S. R., Moretti, M., Zoli, M., Marks, M. J., Zanardi, A., Pucci, L., Clementi, F., & Gotti, C. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.5121-08.2009 · Cited by 222 · see citing works
Self-citationPicciotto, M. R. (2007) · Frontiers in bioscience · doi:10.2741/2695 · Cited by 212 · see citing works
Drenan, R. M., Grady, S. R., Whiteaker, P., McClure-Begley, T., McKinney, S., Miwa, J. M., Bupp, S., Heintz, N., McIntosh, J. M., Bencherif, M., et al. (2008) · Neuron · doi:10.1016/j.neuron.2008.09.009 · Cited by 197 · see citing works
Self-citationα6β2* and α4β2* Nicotinic Acetylcholine Receptors As Drug Targets for Parkinson’s Disease
Quik, M., & Wonnacott, S. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.003269 · Cited by 194 · see citing works
Analogs of α-Conotoxin MII Are Selective for α6-Containing Nicotinic Acetylcholine Receptors
McIntosh, J. M., Azam, L., Staheli, S. T., Dowell, C. D., Lindstrom, J. M., Kuryatov, A., Garrett, J. E., Marks, M. J., & Whiteaker, P. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.4.944 · Cited by 194 · see citing works
Self-citationAlpha-conotoxins as pharmacological probes of nicotinic acetylcholine receptors
Azam, L., & McIntosh, J. M. (2009) · Acta Pharmacologica Sinica · doi:10.1038/aps.2009.47 · Cited by 180 · see citing works
Self-citationBorn to lead? A twin design and genetic association study of leadership role occupancy
Jan-emmanuel De Neve, A., Mikhaylov, S., Dawes, C. T., Christakis, N. A., & Fowler, J. H. (2012) · The Leadership Quarterly · doi:10.1016/j.leaqua.2012.08.001 · Cited by 179 · see citing works
McLaughlin, I., Dani, J. A., & De Biasi, M. (2015) · Current Topics in Behavioral Neurosciences · doi:10.1007/978-3-319-13482-6_4 · Cited by 173 · see citing works
Nicotine Gateway Effects on Adolescent Substance Use
Ren, M., & Lotfipour, S. (2019) · Western Journal of Emergency Medicine · doi:10.5811/westjem.2019.7.41661 · Cited by 166 · see citing works
Cosgrove, K. P., Batis, J., Bois, F., Maciejewski, P. K., Esterlis, I., Kloczynski, T., Stiklus, S., Krishnan-Sarin, S., O’Malley, S., Perry, E., et al. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.41 · Cited by 159 · see citing works
The role of the habenula in drug addiction
Velasquez, K. M., Molfese, D. L., & Salas, R. (2014) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2014.00174 · Cited by 155 · see citing works
The habenulo-interpeduncular pathway in nicotine aversion and withdrawal
Antolin-Fontes, B., Ables, J. L., Görlich, A., & Ibañez-Tallon, I. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.11.019 · Cited by 154 · see citing works
Nicotine and Parkinson's disease: implications for therapy
Quik, M., O'Leary, K., & Tanner, C. M. (2008) · Movement Disorders · doi:10.1002/mds.21900 · Cited by 154 · see citing works
Exposure to nicotine and sensitization of nicotine-induced behaviors
Vezina, P., McGehee, D. S., & Green, W. N. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.08.038 · Cited by 151 · see citing works
Salminen, O., Drapeau, J. A., McIntosh, J. M., Collins, A. C., Marks, M. J., & Grady, S. R. (2007) · Molecular Pharmacology · doi:10.1124/mol.106.031492 · Cited by 149 · see citing works
Self-citationIdentification of embryonic stem cell–derived midbrain dopaminergic neurons for engraftment
Ganat, Y. M., Calder, E. L., Kriks, S., Nelander, J., Tu, E. Y., Jia, F., Battista, D., Harrison, N. L., Parmar, M., Tomishima, M. J., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci58767 · Cited by 139 · see citing works
Genetics of nicotinic acetylcholine receptors: Relevance to nicotine addiction
Mineur, Y. S., & Picciotto, M. R. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.06.010 · Cited by 138 · see citing works
The medial habenula: still neglected
Viswanath, H., Carter, A. Q., Baldwin, P. R., Molfese, D. L., & Salas, R. (2014) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2013.00931 · Cited by 133 · see citing works
Gotti, C., Moretti, M., Clementi, F., Riganti, L., McIntosh, J. M., Collins, A. C., Marks, M. J., & Whiteaker, P. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.011940 · Cited by 133 · see citing works
Self-citationFowler, C. D., Arends, M. A., & Kenny, P. J. (2008) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32830c360e · Cited by 131 · see citing works
Tuesta, L. M., Fowler, C. D., & Kenny, P. J. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.06.026 · Cited by 129 · see citing works
Striatal α6* Nicotinic Acetylcholine Receptors: Potential Targets for Parkinson’s Disease Therapy
Quik, M., & McIntosh, J. M. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.094375 · Cited by 127 · see citing works
Self-citationGotti, C., Moretti, M., Bohr, I. J., Ziabreva, I., Vailati, S., Longhi, R., Riganti, L., Gaimarri, A., McKeith, I. G., Perry, R. H., et al. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.04.005 · Cited by 126 · see citing works
Drenan, R. M., Grady, S. R., Steele, A. D., McKinney, S., Patzlaff, N. E., McIntosh, J. M., Marks, M. J., Miwa, J. M., & Lester, H. A. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.2056-10.2010 · Cited by 127 · see citing works
Self-citationNicotinic acetylcholine receptors: Conventional and unconventional ligands and signaling
Papke, R. L., & Lindstrom, J. M. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108021 · Cited by 123 · see citing works
Neurobiological Mechanisms of Nicotine Reward and Aversion
Wills, L. P., Ables, J. L., Braunscheidel, K. M., Caligiuri, S. P. B., Elayouby, K. S., Fillinger, C., Ishikawa, M., Moen, J. K., & Kenny, P. J. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.121.000299 · Cited by 126 · see citing works
Govind, A. P., Walsh, H., & Green, W. N. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.5438-11.2012 · Cited by 116 · see citing works
Nicotinic Receptors in Neurodegeneration
Posadas, I., López‐Hernández, B., & Ceña, V. (2013) · Current Neuropharmacology · doi:10.2174/1570159x11311030005 · Cited by 113 · see citing works
Lai, A., Parameswaran, N., Khwaja, M., Whiteaker, P., Lindstrom, J. M., Fan, H., McIntosh, J. M., Grady, S. R., & Quik, M. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.006429 · Cited by 112 · see citing works
Self-citationNicke, A., Wonnacott, S., & Lewis, R. J. (2004) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.2004.04145.x · Cited by 109 · see citing works
Graef, S., Schönknecht, P., Sabri, O., & Hegerl, U. (2011) · Psychopharmacology · doi:10.1007/s00213-010-2153-8 · Cited by 107 · see citing works
Molecular and Cellular Mechanisms of Action of Nicotine in the CNS
Barik, J., & Wonnacott, S. (2009) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-69248-5_7 · Cited by 108 · see citing works
Perry, D. C., Mao, D., Gold, A. B., McIntosh, J. M., Pezzullo, J. C., & Kellar, K. J. (2007) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.121228 · Cited by 106 · see citing works
Self-citationWehner, J. M., Keller, J. J., Keller, A. B., Picciotto, M. R., Paylor, R. E., Booker, T. K., Beaudet, A. L., Heinemann, S., & Balogh, S. A. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.07.016 · Cited by 105 · see citing works
Self-citationStriatal α5 Nicotinic Receptor Subunit Regulates Dopamine Transmission in Dorsal Striatum
Exley, R. A., McIntosh, J. M., Marks, M. J., Maskos, U., & Cragg, S. J. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.4985-11.2012 · Cited by 104 · see citing works
Self-citationChernyavsky, A. I., Arredondo, J., Marubio, L. M., & Grando, S. A. (2004) · Journal of Cell Science · doi:10.1242/jcs.01492 · Cited by 102 · see citing works
Drenan, R. M., Nashmi, R., Imoukhuede, P., Just, H., McKinney, S., & Lester, H. A. (2008) · Molecular Pharmacology · doi:10.1124/mol.107.039180 · Cited by 100 · see citing works
Larsson, A. C., Jerlhag, E., Svensson, L., Söderpalm, B., & Engel, J. A. (2004) · Alcohol · doi:10.1016/j.alcohol.2004.10.002 · Cited by 98 · see citing works
Hoft, N. R., Corley, R. P., McQueen, M. B., Schlaepfer, I. R., Huizinga, D. H., & Ehringer, M. A. (2008) · Neuropsychopharmacology · doi:10.1038/npp.2008.122 · Cited by 97 · see citing works
Kuryatov, A., & Lindstrom, J. M. (2010) · Molecular Pharmacology · doi:10.1124/mol.110.066159 · Cited by 97 · see citing works
Brunzell, D. H., Boschen, K. E., Hendrick, E. S., Beardsley, P. M., & McIntosh, J. M. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.171 · Cited by 95 · see citing works
Self-citationInfluence of Neuronal Nicotinic Receptors over Nicotine Addiction and Withdrawal
De Biasi, M., & Salas, R. (2008) · Experimental Biology and Medicine · doi:10.3181/0712-mr-355 · Cited by 95 · see citing works
Quik, M., Perez, X. A., & Grady, S. R. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.06.001 · Cited by 94 · see citing works
Self-citationKuzmin, A. V., Jerlhag, E., Liljequist, S., & Engel, J. A. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1375-5 · Cited by 89 · see citing works
Nicotinic Cholinergic Receptors in the Rat Cerebellum: Multiple Heteromeric Subtypes
Turner, J. R., & Kellar, K. J. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.2112-05.2005 · Cited by 89 · see citing works
Moretti, M., Vailati, S., Zoli, M., Lippi, G., Riganti, L., Longhi, R., Viegi, A., Clementi, F., & Gotti, C. (2004) · Molecular Pharmacology · doi:10.1124/mol.66.1.85 · Cited by 89 · see citing works
Cholinergic left-right asymmetry in the habenulo-interpeduncular pathway
Hong, E., Santhakumar, K., Akitake, C. A., Ahn, S. J., Thisse, C., Thisse, B., Wyart, C., Mangin, J., & Halpern, M. E. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1319566110 · Cited by 82 · see citing works
Evidence of Missense Mutations on the Neuregulin 1 Gene Affecting Function of Prepulse Inhibition
Hong, L. E., Wonodi, I., Stine, O. C., Mitchell, B. D., & Thaker, G. K. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.05.011 · Cited by 84 · see citing works
Janhunen, S. K., & Ahtee, L. (2006) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2006.09.008 · Cited by 81 · see citing works
Xiu, J., Nordberg, A. K., Zhang, J., & Guan, Z.-Z. (2005) · Neurochemistry International · doi:10.1016/j.neuint.2005.04.023 · Cited by 81 · see citing works
Jerlhag, E., Egecioglu, E., Dickson, S. L., Svensson, L., & Engel, J. A. (2008) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2008.02.006 · Cited by 78 · see citing works
Nicotinic acetylcholine receptor inhibitors derived from snake and snail venoms
Dutertre, S., Nicke, A., & Tsetlin, V. I. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.06.011 · Cited by 77 · see citing works
Azam, L., Maskos, U., Changeux, J., Dowell, C. D., Christensen, S. B., Biasi, M. D., & McIntosh, J. M. (2010) · The FASEB Journal · doi:10.1096/fj.10-166272 · Cited by 77 · see citing works
Self-citationJerlhag, E., Grøtli, M., Luthman, K., Svensson, L., & Engel, J. A. (2006) · Alcohol and Alcoholism · doi:10.1093/alcalc/agl049 · Cited by 77 · see citing works
An autoradiographic survey of mouse brain nicotinic acetylcholine receptors defined by null mutants
Baddick, C. G., & Marks, M. J. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.04.019 · Cited by 75 · see citing works
Self-citationGreenbaum, L., & Lerer, B. (2009) · Molecular Psychiatry · doi:10.1038/mp.2009.59 · Cited by 73 · see citing works
McClure‐Begley, T. D., King, N. M., Collins, A. C., Stitzel, J. A., Wehner, J. M., & Butt, C. M. (2009) · Molecular Pharmacology · doi:10.1124/mol.108.052274 · Cited by 72 · see citing works
Self-citationPortugal, G. S., & Gould, T. J. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.05.006 · Cited by 71 · see citing works
Gotti, C., Moretti, M., Zanardi, A., Gaimarri, A., Champtiaux, N., Changeux, J., Whiteaker, P., Marks, M. J., Clementi, F., & Zoli, M. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.015925 · Cited by 71 · see citing works
Self-citationKing, S. L., Caldarone, B. J., & Picciotto, M. R. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.06.024 · Cited by 70 · see citing works
Tsetlin, V. I., Utkin, Y. N., & Kasheverov, I. E. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.05.032 · Cited by 69 · see citing works
The Role of the Habenula in Nicotine Addiction
Baldwin, P. R., Alanis, R., & Salas, R. (2012) · Journal of Addiction Research & Therapy · doi:10.4172/2155-6105.s1-002 · Cited by 67 · see citing works
Salminen, O., Whiteaker, P., Grady, S. R., Collins, A. C., McIntosh, J. M., & Marks, M. J. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.12.011 · Cited by 63 · see citing works
Self-citationZhang, J., & Berg, D. K. (2007) · The Journal of Physiology · doi:10.1113/jphysiol.2006.124578 · Cited by 61 · see citing works
Broadbent, S. D., Groot‐Kormelink, P. J., Krashia, P., Harkness, P. C., Millar, N. S., Beato, M., & Sivilotti, L. G. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.026682 · Cited by 60 · see citing works
Meyer, E. L., Yoshikami, D., & McIntosh, J. M. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05266.x · Cited by 58 · see citing works
Self-citationAzam, L., & McIntosh, J. M. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.024513 · Cited by 56 · see citing works
Self-citationKeller, J. J., Keller, A. B., Bowers, B. J., & Wehner, J. M. (2005) · Behavioural Brain Research · doi:10.1016/j.bbr.2005.03.004 · Cited by 57 · see citing works
Giribaldi, J., & Dutertre, S. (2017) · Neuroscience Letters · doi:10.1016/j.neulet.2017.11.063 · Cited by 57 · see citing works
Whiteaker, P., Cooper, J. F., Salminen, O., Marks, M. J., McClure‐Begley, T. D., Brown, R. W. B., Collins, A. C., & Lindstrom, J. M. (2006) · The Journal of Comparative Neurology · doi:10.1002/cne.21181 · Cited by 56 · see citing works
Self-citationNicotinic receptor-based therapeutics and candidates for smoking cessation
Dwoskin, L. P., Smith, A. M., Wooters, T. E., Zhang, Z., Crooks, P. A., & Bardo, M. T. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.06.002 · Cited by 56 · see citing works
Interplay between Smoking-induced Genotoxicity and Altered Signaling in Pancreatic Carcinogenesis
Momi, N., Kaur, S., Ponnusamy, M. P., Kumar, S., Wittel, U. A., & Batra, S. K. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs186 · Cited by 54 · see citing works
Khwaja, M., McCormack, A., McIntosh, J. M., Di Monte, D. A., & Quik, M. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04177.x · Cited by 54 · see citing works
Self-citationNicotinic Receptor Antagonists as Treatments for Nicotine Abuse
Crooks, P. A., Bardo, M. T., & Dwoskin, L. P. (2014) · Advances in pharmacology · doi:10.1016/b978-0-12-420118-7.00013-5 · Cited by 54 · see citing works
McCallum, S. E., Parameswaran, N., Bordia, T., McIntosh, J. M., Grady, S. R., & Quik, M. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.012773 · Cited by 52 · see citing works
Self-citationEndo, T., Yanagawa, Y., Obata, K., & Isa, T. (2005) · Journal of Neurophysiology · doi:10.1152/jn.00211.2005 · Cited by 52 · see citing works
Drenan, R. M., & Lester, H. A. (2012) · Pharmacological Reviews · doi:10.1124/pr.111.004671 · Cited by 51 · see citing works
Engle, S. E., Shih, P.-Y., McIntosh, J. M., & Drenan, R. M. (2013) · Molecular Pharmacology · doi:10.1124/mol.113.087346 · Cited by 51 · see citing works
Self-citationNicotinic Cholinergic Receptors in the Rat Retina: Simple and Mixed Heteromeric Subtypes
Marritt, A. M., Cox, B. C., Yasuda, R. P., McIntosh, J. M., Xiao, Y., Wolfe, B. B., & Kellar, K. J. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.012369 · Cited by 50 · see citing works
Self-citationDecreased anxiety-like behavior in beta3 nicotinic receptor subunit knockout mice
Booker, T. K., Butt, C. M., Wehner, J. M., Heinemann, S. F., & Collins, A. C. (2007) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2007.04.011 · Cited by 49 · see citing works
Self-citationNicotinic cholinergic mechanisms causing elevated dopamine release and abnormal locomotor behavior
Cohen, B. N., Mackey, E. D. W., Grady, S. R., McKinney, S. L., Patzlaff, N. E., Wageman, C. R., McIntosh, J. M., Marks, M. J., Lester, H. A., & Drenan, R. M. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.10.047 · Cited by 47 · see citing works
Self-citationRezvani, K., Teng, Y., Pan, Y., Dani, J. A., Lindstrom, J., García Gras, E. A., McIntosh, J. M., & De Biasi, M. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.4723-08.2009 · Cited by 46 · see citing works
Self-citationBorroni, V., & Barrantes, F. J. (2021) · Membranes · doi:10.3390/membranes11090664 · Cited by 47 · see citing works
Structure of Neuronal Nicotinic Receptors
Fasoli, F., & Gotti, C. (2015) · Current topics in behavioral neurosciences · doi:10.1007/978-3-319-13665-3_1 · Cited by 45 · see citing works
The Role of Nicotine in Schizophrenia
Featherstone, R. E., & Siegel, S. J. (2015) · International review of neurobiology · doi:10.1016/bs.irn.2015.07.002 · Cited by 46 · see citing works
- Authors
- Cui, C., Booker, T. K., Allen, R. S., Grady, S. R., Whiteaker, P., Marks, M. J., Salminen, O., Tritto, T., Butt, C. M., Allen, W. R., Stitzel, J. A., McIntosh, J. M., Boulter, J., Collins, A. C., & Heinemann, S. F.
- Affiliations
- Salk Institute for Biological Studies (US)
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2003-12-03
- Volume
- 23
- Issue
- 35
- Pages
- 11045-11053
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- PMC
- PMC6741047
- OpenAlex
- W2130326884
- Cited by
- 213
- References
- 53
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 3 · 2023: 2 · 2022: 2 · 2021: 2 · 2020: 3 · 2019: 4 · 2018: 4 · 2017: 6 · 2016: 10 · 2015: 6 · 2014: 17 · 2013: 9 · 2012: 12
- FWCI
- 5.52
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5k05da000197-07, 5p01da010156-05, MH53631)
- National Institute on Aging (2T32AG00216, T32AG000216)
- National Institute of Mental Health (MH53631, R01MH053631, R29MH053631)
- National Institute on Drug Abuse (DA00197, DA-14369, R01DA014369, R01DA012242, DA10156, DA12242)
- National Institute of Neurological Disorders and Stroke (NS10830, F32NS010830)
- National Institute of Child Health and Human Development
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Physiology › Smoking Behavior and Cessation
- Keywords
- nicotinic acetylcholine receptors, beta3 subunit, alpha-conotoxin MII, dopamine release, nigrostriatal pathway, substantia nigra, ventral tegmental area, null mice, locomotor activity, prepulse inhibition, acoustic startle response, mesolimbic dopamine system, striatum
- MeSH terms
- Animals, Behavior, Animal, Binding, Competitive, Corpus Striatum, Dopamine, Dose-Response Relationship, Drug, Female, Ligands, Male, Mice, Mutant Strains, Motor Activity, Neural Inhibition, Nicotine, Receptors, Nicotinic, RNA, Messenger, Reflex, Startle, Substantia Nigra, Synaptosomes, In Situ Hybridization, Mice, Knockout, Gene Targeting, Conotoxins, Protein Subunits, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review